SCHEMBL2933394

SCHEMBL2933394

Cc1ccccc1Pc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.43
ACHE P22303 3/20 0.43
LMNA P02545 1/20 0.35
ALOX12 P18054 1/20 0.35
ALDH1A1 P00352 4/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA7 P43166 2/20 0.35
CA9 Q16790 2/20 0.35
CYP3A4 P08684 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP2A6 P11509 2/20 0.32
CYP1A2 P05177 2/20 0.32
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30
ESR1 P03372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14603956 0.98 TSHR (0.41) TSHRACHELMNAALOX12ALDH1A1
SCHEMBL28379430 0.98 TSHR (0.41) TSHRACHELMNAALOX12ALDH1A1
Hydrochloric Acid SCHEMBL28380243 0.98 TSHR (0.41) TSHRACHELMNAALOX12ALDH1A1
Hydrochloric Acid SCHEMBL2154269 0.98 TSHR (0.41) TSHRACHELMNAALOX12ALDH1A1
SCHEMBL8165675 0.93 TSHR (0.41) TSHRACHELMNAALOX12ALDH1A1
SCHEMBL11311009 0.86 ACHE (0.39) TSHRACHELMNAALOX12ALDH1A1
SCHEMBL3629579 0.86 ACHE (0.39) TSHRACHEALDH1A1CA1CA2
SCHEMBL9852854 0.84 TRPA1 (0.38) TSHRACHELMNAALOX12ALDH1A1
SCHEMBL146928 0.84 TSHR (0.53) TSHRACHELMNAALOX12ALDH1A1
Water SCHEMBL31324050 0.82 TRPA1 (0.37) TSHRACHELMNAALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115010734-B Compound, display panel and display device 武汉天马微电子有限公司 2024-08-06 CN disclosed
CN-115850329-A Cycloterpyriaryl phosphines, their preparation and use 东莞市均成高新材料有限公司 2023-03-28 CN disclosed
EP-3150613-A1 P-CHIROGENIC ORGANOPHOSPHORUS COMPOUNDS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2017-04-05 EP disclosed
EP-2731956-B1 P-CHIROGENIC ORGANOPHOSPHORUS COMPOUNDS CENTRE NAT RECH SCIENT (FR) 2016-11-09 EP disclosed
CN-104271545-B The manufacture method of branched chain aldehyde MITSUBISHI GAS CHEMICAL CO.,INC. (JP) 2016-03-30 CN disclosed
CN-104271545-A Method for producing branched chain aldehyde MITSUBISHI GAS CHEMICAL CO 2015-01-07 CN disclosed
US-8461248-B2 Resin composition and molded product thereof, and method for their production SONY CORPORATION (JP) 2013-06-11 US disclosed
EP-2230275-B1 Resin composition and molded product thereof, and method for their production SONY CORP (JP) 2012-11-21 EP disclosed
CN-101155854-B Curing-accelerating compound-silica composite, method for producing curing-accelerating compound-silica composite, curing accelerator, curable resin composition, and electronic component device HITACHI CHEMICAL CO LTD 2011-09-07 CN disclosed
US-20110201844-A1 CATALYST COMPOSITION FOR HYDROFORMYLATION AND METHOD FOR PRODUCING ALDEHYDE USING THE SAME LG CHEM, LTD. (KR) 2011-08-18 US disclosed
CN-1216059-C Phosphonium salts, process for producing the same, use thereof, phosphine produced from the phosphonium salts and process for producing the same KURARAY CO (JP) 2005-08-24 CN disclosed
WO-2005040277-A1 FLAME RETARDANT EPOXY PREPREGS, LAMINATES, AND PRINTED WIRING BOARDS OF ENHANCED THERMAL STABILITY ALBEMARLE CORPORATION (US) 2005-05-06 WO disclosed
US-20050075024-A1 Flame retardant epoxy prepregs, laminates, and printed wiring boards of enhanced thermal stability ALBEMARLE CORPORATION 2005-04-07 US disclosed
US-6683136-B2 OF A NITRILE COPOLYMER RUBBER, USING A HYDROGENATION CATALYST, A COCATALYST, AND A PROTON ACCEPTOR THAT IS NON-COORDINATING WITH THE METAL COMPLEX CATALYST, SUCH AS EPOXIDIZED SOYBEAN OIL (ESBO) BAYER INC. (CA) 2004-01-27 US disclosed
CN-1384106-A Phosphonium salts, process for producing the same, use thereof, phosphine produced from the phosphonium salts and process for producing the same KURARAY CO (JP) 2002-12-11 CN disclosed
US-20020128393-A1 Esbo enhanced hydrogenation LANXESS INC. (CA) 2002-09-12 US disclosed
CN-1096286-A The method for preparing the alkadiene alcohol compound MITSUBISHI CHEM IND (JP) 1994-12-14 CN disclosed
US-5288912-A Hydrohalogenation of a triarylphosphine; alkylation; using lithium diarylphosphine as chemical intermediate EASTMAN KODAK COMPANY (US) 1994-02-22 US disclosed
US-4293502-A CATALYST FOR OLIGOMERIZATION OF ETHYLENE GULF RESEARCH & DEVELOPMENT COMPANY (US) 1981-10-06 US disclosed
US-3951661-A Silver halide emulsion containing an arylphosphonium salt as antifoggant KONISHIROKU PHOTO INDUSTRY CO. (JA) 1976-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201844-A1 CATALYST COMPOSITION FOR HYDROFORMYLATION AND METHOD FOR PRODUCING ALDEHYDE USING THE SAME ALDH3A1, ALDH2, ALDH5A1 TSHR 3164/4885ACHE 2686/4885LMNA 4679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.